GENEP
GenEp, Inc. is a pre-clinical stage biotechnology company based on intellectual property assets. GenEp creates therapies targeting mutations of sodium and other ion channels that cause rare genetic epilepsies and other treatment-resistant epilepsies.
GENEP
Industry:
Biotechnology
Status:
Active
Contact:
434-989-6299
Email Addresses:
[email protected]
Total Funding:
1.45 M USD
Similar Organizations
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Current Advisors List
Current Employees Featured
Investors List
Angelini Lumira Biosciences Fund
Angelini Lumira Biosciences Fund investment in Seed Round - GenEp
Kids Connect Charitable Fund
Kids Connect Charitable Fund investment in Seed Round - GenEp
UVA Licensing & Ventures Group
UVA Licensing & Ventures Group investment in Seed Round - GenEp
Virginia Innovation Partnership Corporation
Virginia Innovation Partnership Corporation investment in Seed Round - GenEp
3B Future Health Fund
3B Future Health Fund investment in Seed Round - GenEp
PDI Ventures
PDI Ventures investment in Seed Round - GenEp